Quantcast

Latest TRIANGLE PARK Stories

2008-10-30 12:01:03

Pathfinder Therapeutics, Inc. (PTI), a medical device company focused on the development of "surgical GPS" systems for the abdomen, announced that it has closed on a $5.2 million Series A financing round led by Hatteras Venture Partners of Research Triangle Park, NC. Other investors included Florida Gulfshore Capital, Clayton & Associates, Nashville Capital Network, Lumira, and Vanderbilt University. Concurrent with the financing, Clay Thorp and Bob Morff, PhD, from Hatteras Venture...

2008-10-09 09:00:10

RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today the start of a Phase II proof-of-concept clinical trial to evaluate the safety and efficacy of senicapoc, the Company's novel orally available small molecule inhibitor of the KCa3.1 potassium ion channel, in patients with allergic asthma. Results from a preclinical study demonstrated the ability of senicapoc to reverse antigen-induced increases in airway resistance and airway...

2008-09-23 12:00:13

A study of a treatment for chronic inflammatory demyelinating neuropathy (CIDP) suggests that 50 percent of the patients who responded to treatment with Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) required two treatments before they first exhibited improvements on a standard disability measurement scale, according to data presented at the American Neurological Association meeting in Salt Lake City, Utah. The study authors concluded that "further...

2008-09-22 18:00:12

RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today, at the 15th International Inflammation Research Association Conference in Chantilly, Virginia, results from a preclinical study demonstrating effects of senicapoc in isolated human lung mast cells. Senicapoc, the Company's novel orally available small molecule inhibitor of the KCa3.1 potassium ion channel, was shown to potently block KCa3.1 potassium currents in isolated human lung mast...

2008-09-08 09:00:11

RESEARCH TRIANGLE PARK, N.C., Sept. 8 /PRNewswire/ -- TapRoot Systems, Inc., a leading developer of software solutions for the smartphone market, today announced that its "always-with-you" WalkingHotSpot(TM) internet connectivity solution is available for all consumers to purchase directly from http://www.walkinghotspot.com/. Initially launched earlier this year, WalkingHotSpot has been successfully tested for the last five months by thousands of beta-testers on major wireless networks....

2008-09-08 09:00:11

SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 8 /PRNewswire/ -- Trinity Convergence, a leading developer of communications and multimedia device software, today launched gloop(TM), the world's first true peer-to-peer photo sharing software technology for digital photo frames and other digital displays. Trinity Convergence unveiled gloop digital photo sharing technology today at DEMOfall 08. gloop technology is designed for digital photo frame OEMs looking to differentiate their...

2008-09-04 12:00:32

RESEARCH TRIANGLE PARK, N.C., Sept. 4 /PRNewswire/ -- The Hamner Institutes for Health Sciences and the University of North Carolina at Chapel Hill announced they are establishing a joint Center for Drug Safety Sciences that will be led by Dr. Paul Watkins, one of the world's leading experts in drug-induced liver injury. As founding director for this innovative new research center, Watkins will develop new drug-safety initiatives with academic partners, the bio/pharmaceutical industry, the...

2008-07-21 12:01:26

RESEARCH TRIANGLE PARK, N.C., July 21 /PRNewswire/ -- AlphaVax announced today the initiation of a Chlamydia vaccine program based on its alphavirus vector platform technology. Genital chlamydial infections, caused by the bacterium Chlamydia trachomatis, have been shown to be the most prevalent bacterial sexually transmitted disease worldwide. Although antibiotic therapy is available, it is usually a "silent" undetected infection, showing no symptoms in three-quarters of all infected women...

2008-07-09 09:00:12

RESEARCH TRIANGLE PARK, N.C., July 9, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported that the Company successfully completed the Phase I multiple ascending dose clinical trial of senicapoc, a novel orally available small molecule inhibitor of the KCa3.1 potassium ion channel, that is being developed for the treatment of asthma. Study results showed that senicapoc was well tolerated at all doses tested and in preliminary analyses exhibited predictable and dose proportional...

2008-06-24 02:29:38

RESEARCH TRIANGLE PARK, N.C., June 23 /PRNewswire/ -- ChannelAdvisor (http://www.channeladvisor.com/), the leading provider of e-commerce channel management solutions, today announced the launch of SearchAdvisor's new Multi-Channel Assist feature that evaluates the impact of paid search keywords and comparison shopping ads that contribute to online purchasing decisions. Retailers can incorporate these metrics into automatic bidding rules for increased profitability across multiple e-commerce...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.